Can amiodarone cause appetite loss in patients, particularly those with pre-existing gastrointestinal issues or taking other medications that suppress appetite?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Amiodarone Cause Appetite Loss?

Amiodarone does not typically cause appetite loss as a recognized adverse effect. The extensive adverse effect profile of amiodarone includes gastrointestinal symptoms, but these manifest primarily as nausea, vomiting, and constipation rather than appetite suppression.

Documented Gastrointestinal Effects

The gastrointestinal adverse effects of amiodarone are well-characterized but do not include appetite loss:

  • Constipation is the most common gastrointestinal complaint, occurring in the majority of patients on amiodarone therapy 1, 2.
  • Nausea and vomiting are documented gastrointestinal side effects that occur during amiodarone treatment 3, 1.
  • Gastrointestinal upset occurs frequently enough that it is listed among the primary adverse effects in major guidelines 3.

In a study of 70 consecutive patients treated with amiodarone, 56 patients (80%) experienced gastrointestinal side effects, with constipation being the predominant complaint 1. Another comprehensive review noted that gastrointestinal adverse effects are part of the diverse adverse effect profile but specifically identified nausea, vomiting, and constipation as the manifestations 2, 4.

Why Appetite Loss Is Not Documented

The absence of appetite loss from the extensive literature on amiodarone toxicity is notable:

  • Multiple comprehensive guidelines and reviews cataloging amiodarone's adverse effects across all organ systems do not list appetite loss or anorexia 3, 5.
  • Studies specifically examining side effects in 93% of patients found gastrointestinal complaints but did not identify appetite suppression 1.
  • The American Academy of Family Physicians' systematic organ-based approach to amiodarone toxicity monitoring does not include appetite assessment 3, 5.

Clinical Context for Patients with Pre-existing GI Issues

For patients with pre-existing gastrointestinal conditions or those taking other appetite-suppressing medications:

  • The primary concern is exacerbation of constipation, which is nearly universal with amiodarone and may worsen underlying GI motility disorders 1, 2.
  • Nausea from amiodarone could theoretically reduce food intake, but this is distinct from true appetite suppression and is typically dose-related 3, 1.
  • If a patient on amiodarone develops appetite loss, investigate alternative causes rather than attributing it to amiodarone, including thyroid dysfunction (both hypothyroidism and hyperthyroidism occur with amiodarone), hepatic toxicity, or cardiac decompensation 3, 5.

Common Pitfall to Avoid

Do not attribute appetite loss to amiodarone without thoroughly investigating other causes, particularly amiodarone-induced thyroid dysfunction, which can present with appetite changes, or worsening heart failure, which commonly causes anorexia 3, 5. The American Academy of Family Physicians recommends monitoring thyroid function every 6 months in patients on amiodarone, as both hypothyroidism and hyperthyroidism can affect appetite 3, 5.

References

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Research

Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.

Journal of the American College of Cardiology, 1984

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Toxicity Diagnosis and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.